The New Advantages and Perspectives of Latanoprost (Xalatan, Pfizer, USA) Treatment in Pseudoexfoliation Glaucoma
Ophthalmology journal
doi 10.17816/ov2013161-65
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2013
Authors
Publisher
ECO-Vector LLC